Pursuant to Regulation 30 of the SEBI Listing Regulations, please find attached Draft Letter of Offer filed by the Manager to the Offer with SEBI yesterday, relating to the mandatory open ....
M&A
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 09 Jun 2026, 07:49 PM IST · BSE ID: 9a6cbc9f-b255-4f37-b53e-8907340b869a
View Original BSE Filing (PDF)
💡
In Simple Terms
Anupam Rasayan India submitted a formal proposal to SEBI to buy a 26% stake in Bliss GVS Pharma from public shareholders.
🤖 AI Summary
- Anupam Rasayan India filed Draft Letter of Offer for mandatory open offer for Bliss GVS Pharma Limited.
- The open offer is to acquire up to 2,77,26,848 fully paid-up equity shares of Bliss GVS Pharma.
- Offer price is ₹ 299.00 per equity share, representing 26.00% of the target company's capital.
- SBI Capital Markets Limited is acting as the Manager to the Offer for this transaction.
- The open offer complies with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Offer Shares Quantity
2,77,26,848
Offer Price per Equity Share
₹ 299.00
Percentage of Expanded Voting Share Capital
26.00%
🏢 How This Affects the Company
This open offer signifies Anupam Rasayan India's intent to expand its business footprint by acquiring a significant stake in Bliss GVS Pharma Limited, a pharmaceutical company.
The acquisition involves a cash offer for shares, which will impact Anupam Rasayan India's cash reserves or require financing to fund the acquisition of 2,77,26,848 shares at ₹ 299.00 each.
The completion of the open offer and subsequent integration carry inherent risks related to regulatory approvals, shareholder acceptance, and post-acquisition business performance.
👥 What This Means For Shareholders
✅
Action Required
Public shareholders of Bliss GVS Pharma Limited will be sent the Letter of Offer and Form of Acceptance-cum-Acknowledgement for tendering their shares.
👤
Who Is Affected
Public shareholders of Bliss GVS Pharma Limited are affected, as Anupam Rasayan India is making a cash offer to acquire up to 2,77,26,848 of their equity shares at ₹ 299.00 per share.
🔍
Management Signal
Anupam Rasayan India's management is proceeding with the strategic acquisition of a significant stake in Bliss GVS Pharma Limited, signaling expansion intent.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
SEBI's approval status for the Draft Letter of Offer.
Announcement of the final Letter of Offer and offer schedule.
Outcome of the open offer, including shares tendered and acceptance.
MEDIUM RISK
Acquisition proceedings carry regulatory approval risks and execution risks, with no guaranteed outcome for the open offer.
💡 Investor Takeaway
Anupam Rasayan India has filed its Draft Letter of Offer with SEBI for a mandatory open offer to acquire 26.00% of Bliss GVS Pharma Limited's expanded voting capital. The offer price is ₹ 299.00 per equity share, targeting 2,77,26,848 shares.
⚖️ Strengths & Concerns
✅ Positives
- The open offer provides a clear acquisition strategy for Anupam Rasayan India to expand its interest in Bliss GVS Pharma Limited.
- The fixed offer price of ₹ 299.00 per equity share offers transparency to public shareholders of Bliss GVS Pharma.
⚠️ Concerns
- No immediate financial benefits for Anupam Rasayan India are disclosed in the filing, as it is a preliminary step in the acquisition process.
- The filing does not detail the total financial outlay for Anupam Rasayan India or potential impact on its debt levels.
❓ Frequently Asked Questions
What is the purpose of Anupam Rasayan India's latest filing?
Anupam Rasayan India has filed the Draft Letter of Offer with SEBI for a mandatory open offer to public shareholders of Bliss GVS Pharma Limited.
How many shares is Anupam Rasayan India looking to acquire in Bliss GVS Pharma?
Anupam Rasayan India aims to acquire up to 2,77,26,848 fully paid-up equity shares of Bliss GVS Pharma Limited.
What is the offer price per equity share for Bliss GVS Pharma?
The offer price is ₹ 299.00 (Indian Rupees Two Hundred Ninety-Nine Only) per equity share of Bliss GVS Pharma Limited.
What percentage of Bliss GVS Pharma's capital does this open offer represent?
The open offer represents 26.00% (Twenty-Six Per Cent.) of the expanded voting share capital of Bliss GVS Pharma Limited.
Who is the Manager to the Offer for this transaction?
SBI Capital Markets Limited has been appointed as the Manager to the Offer for this mandatory open offer by Anupam Rasayan India.
Questions based on this BSE filing only. For information purposes.